Hims & Hers Health (NYSE:HIMS) Trading 5.8% Higher

Shares of Hims & Hers Health, Inc. (NYSE:HIMS) were up 5.8% during trading on Monday . The company traded as high as $20.58 and last traded at $20.54. Approximately 3,946,730 shares traded hands during trading, a decline of 47% from the average daily volume of 7,432,600 shares. The stock had previously closed at $19.42.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. TD Cowen raised their target price on shares of Hims & Hers Health from $15.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, July 11th. Canaccord Genuity Group lifted their price objective on shares of Hims & Hers Health from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, May 22nd. Canaccord Genuity Group started coverage on Hims & Hers Health in a report on Wednesday, April 10th. They issued a “buy” rating and a $20.00 target price for the company. Jefferies Financial Group lifted their price target on Hims & Hers Health from $14.00 to $23.00 and gave the company a “hold” rating in a report on Thursday, June 27th. Finally, Piper Sandler increased their price objective on Hims & Hers Health from $16.00 to $18.00 and gave the stock a “neutral” rating in a research note on Thursday, July 11th. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.07.

Hims & Hers Health Trading Up 4.7 %

The firm has a market capitalization of $4.37 billion, a price-to-earnings ratio of -2,051.00 and a beta of 1.08. The company has a fifty day moving average price of $20.24 and a 200-day moving average price of $14.85.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, May 6th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Hims & Hers Health had a negative net margin of 0.24% and a negative return on equity of 0.70%. The firm had revenue of $278.20 million during the quarter, compared to analysts’ expectations of $270.37 million. During the same period in the previous year, the company earned ($0.05) earnings per share. The company’s revenue was up 45.8% compared to the same quarter last year. As a group, sell-side analysts predict that Hims & Hers Health, Inc. will post 0.2 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Michael Chi sold 7,500 shares of the stock in a transaction dated Thursday, June 20th. The stock was sold at an average price of $24.50, for a total transaction of $183,750.00. Following the transaction, the insider now owns 185,326 shares of the company’s stock, valued at approximately $4,540,487. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, insider Michael Chi sold 7,500 shares of the business’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $24.50, for a total value of $183,750.00. Following the completion of the sale, the insider now directly owns 185,326 shares in the company, valued at $4,540,487. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Melissa Baird sold 11,750 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.08, for a total transaction of $141,940.00. Following the completion of the transaction, the chief operating officer now owns 538,932 shares in the company, valued at $6,510,298.56. The disclosure for this sale can be found here. Insiders have sold 981,653 shares of company stock valued at $18,588,465 over the last three months. 17.71% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Hims & Hers Health

A number of institutional investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC grew its holdings in Hims & Hers Health by 679.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after buying an additional 1,603 shares during the last quarter. Certuity LLC acquired a new stake in shares of Hims & Hers Health in the fourth quarter worth $109,000. Belpointe Asset Management LLC increased its position in Hims & Hers Health by 10.0% during the fourth quarter. Belpointe Asset Management LLC now owns 13,238 shares of the company’s stock worth $118,000 after acquiring an additional 1,205 shares during the period. Custom Index Systems LLC bought a new position in Hims & Hers Health during the fourth quarter worth $132,000. Finally, B. Riley Wealth Advisors Inc. acquired a new position in Hims & Hers Health during the 4th quarter valued at $155,000. 63.52% of the stock is currently owned by institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.